Status:
COMPLETED
Impact of Exercise Intervention on Well-being in Shift-working Acute Care Nurses
Lead Sponsor:
AdventHealth
Conditions:
Psychological Wellness
Eligibility:
All Genders
21-65 years
Phase:
NA
Brief Summary
This is a randomized, wait-list control pilot study to analyze the impact of a 12-week exercise training intervention on post-traumatic growth and whole-person well-being (mental health, physical heal...
Detailed Description
This study has five phases: Phase I: Screening; Phase II: Baseline Assessments (Pre-Intervention); Phase III: Exercise training; Phase IV: Post-Intervention; and Phase V: Repeat assessments at 3-month...
Eligibility Criteria
Inclusion
- Inclusion:
- Age 21-65 years
- Nurse working in an AdventHealth inpatient acute care setting
- Currently working as a shift-working acute care nurse within AdventHealth.
- Weight stable prior to beginning the study exercise training intervention.
- Able to speak and understand written and spoken English.
- Understands the procedures and agrees to participate by giving written informed consent.
- Willing and able to comply with scheduled visits, laboratory tests, and other study procedures including a 12-week exercise training program.
- Exclusion Criteria:
- Positive urine pregnancy test prior to DEXA scan
- Uncontrolled Type 1 or Type 2 diabetes mellitus
- Bleeding disorders
- Acute or chronic infections
- Chronic obstructive pulmonary disease
- Renal insufficiency or nephritis
- Uncontrolled hypertension (BP\>160 mmHg systolic or \>100 mmHg diastolic)
- History of Cushing's disease or syndrome
- Active rheumatoid arthritis or other inflammatory rheumatic disorder
- Major surgery within 4 weeks prior to Screening
- Participation in studies involving investigational drug(s) within 30 days prior to Screening
- History or presence of cardiovascular disease (unstable angina, myocardial infarction or coronary revascularization within 6 months, presence of cardiac pacemaker, implanted cardiac defibrillator)
- Any malignancy not considered cured, except basal cell carcinoma and squamous cell carcinoma of the skin (a participant is considered cured if there has been no evidence of cancer recurrence in the previous 5 years)
- Presence of any condition that, in the opinion of the Investigator or medical investigator, compromises participant safety or data integrity or the participant's ability to complete study days.
- More than 1-day a week of intentional exercise
- Medically diagnosed sleep disorder
- Weight \>450 lbs
Exclusion
Key Trial Info
Start Date :
September 13 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 13 2025
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT05966805
Start Date
September 13 2023
End Date
May 13 2025
Last Update
November 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AdventHealth
Orlando, Florida, United States, 32803